Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIVAROXABAN vs ROMIDEPSIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIVAROXABAN vs ROMIDEPSIN: Safety Overview

Metric RIVAROXABAN ROMIDEPSIN
Total FAERS Reports 131,274 1,282
Deaths Reported 19,233 343
Death Rate 14.7% 26.8%
Hospitalizations 70,513 458
Average Patient Age 70.0 yrs 64.7 yrs
% Female Patients 47.7% 46.5%
FDA Approval Date Apr 10, 2025 Mar 13, 2020
Manufacturer Macleods Pharmaceuticals Limited Fresenius Kabi USA, LLC
Route ORAL N/A
Marketing Status Prescription Prescription